Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-60,000
Closed -$849K 3803
2014
Q4
$849K Hold
60,000
﹤0.01% 2951
2014
Q3
$1.02M Hold
60,000
﹤0.01% 2791
2014
Q2
$1.79M Sell
60,000
-14,460
-19% -$347K ﹤0.01% 2398
2014
Q1
$1.86M Hold
74,460
﹤0.01% 2461
2013
Q4
$2.14M Hold
74,460
﹤0.01% 2472
2013
Q3
$2.45M Buy
74,460
+24,820
+50% +$772K ﹤0.01% 2244
2013
Q2
$1.54M Buy
+49,640
New +$1.33M ﹤0.01% 2362

Other funds holding INVA

David Shaw's INVA Position: Q2 2026 in Review

David Shaw reduced its Innoviva (INVA) stake by 33% in Q2 2026, selling an estimated $1.89M and leaving 166,255 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

David Shaw first reported a position in INVA in Q3 2013 and has held it in 52 quarters since. The position peaked at $34.1M in Q4 2018. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • David Shaw held 166,255 shares of Innoviva worth $3.78M as of Q2 2026.
  • David Shaw sold 82,564 Innoviva shares in Q2 2026, an estimated $1.89M.
  • Innoviva made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2651 holding.
  • David Shaw first reported a position in Innoviva in Q3 2013 and has held it in 52 quarters since.
  • David Shaw's Innoviva position peaked at $34.1M in Q4 2018.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.